Veery Capital’s AstraZeneca AZN Stock Holding History

Veery Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$339K	Buy	+1,787	New	+$336K	0.09%	68
2026 Q1	–	Sell	-1,885	Closed	-$347K	–	98
2025 Q4	$347K	Buy	1,885 +19	+1%	+$3.33K	0.11%	59
2025 Q3	$286K	Buy	1,866 +27	+1%	+$4.09K	0.09%	66
2025 Q2	$257K	Sell	1,839 -77	-4%	-$10.8K	0.09%	71
2025 Q1	$282K	Buy	1,916 +164	+9%	+$23.7K	0.11%	60
2024 Q4	$230K	Buy	1,752 +79	+5%	+$11.1K	0.09%	75
2024 Q3	$261K	Sell	1,673 -25	-1%	-$4.04K	0.1%	75
2024 Q2	$265K	Sell	1,698 -70	-4%	-$10.5K	0.11%	79
2024 Q1	$240K	Buy	1,768 +23	+1%	+$3.05K	0.1%	81
2023 Q4	$235K	Buy	+1,745	New	+$227K	0.11%	79
2023 Q3	–	Sell	-1,506	Closed	-$216K	–	84
2023 Q2	$216K	Buy	+1,506	New	+$222K	0.1%	79
2022 Q2	–	Sell	-1,505	Closed	-$200K	–	75
2022 Q1	$200K	Buy	+1,505	New	+$180K	0.11%	79

Other funds holding AZN

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ZIC

ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

CAM

Cidel Asset Management Toronto, Ontario, Ontario, Canada $2.08B AUM 24.89% 1-Year Est. Return

SAM

Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return

PAS

Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return

MIM

Martin Investment Management Palm Beach Gardens, Florida $300M AUM 6.05% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Veery Capital's AZN Position: Q2 2026 in Review

Veery Capital opened a new position in AstraZeneca (AZN) in Q2 2026: 1,787 shares worth $339K. The stake represents 0.09% of the portfolio and ranks #68 among its holdings. This is a return to the name: Veery Capital previously reported a position in AZN as recently as Q4 2025.

Veery Capital first reported a position in AZN in Q1 2022 and has held it in 12 quarters since. The position peaked at $347K in Q4 2025. 233 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Veery Capital held 1,787 shares of AstraZeneca worth $339K as of Q2 2026.
AstraZeneca was a new Veery Capital position in Q2 2026.
AstraZeneca made up 0.09% of Veery Capital's portfolio in Q2 2026, its #68 holding.
Veery Capital first reported a position in AstraZeneca in Q1 2022 and has held it in 12 quarters since.
Veery Capital's AstraZeneca position peaked at $347K in Q4 2025.
233 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Veery Capital's 13F filing for Q2 2026, filed 9 Jul 2026.